Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Laminin subunit beta-2 is a protein encoded by the LAMB2 gene and is a member of the laminin family of extracellular matrix glycoproteins, which are the main non-collagenous components of basement membranes. Laminins are heterotrimers made of alpha, beta, and gamma chains; the beta-2 chain (LAMB2) plays a critical role in the structure of the basement membrane and is particularly enriched in the neuromuscular junction, kidney glomerulus, and vascular smooth muscle. LAMB2 is involved in cell adhesion, differentiation, migration, and organization into tissues, especially during embryonic development. Genetic mutations in LAMB2 are associated with Pierson syndrome, nephrotic syndrome type 5, ocular abnormalities, and synaptic congenital myasthenic syndromes. The protein is also a prognostic marker in certain cancers, such as kidney renal clear cell carcinoma and rectum adenocarcinoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Laminin subunit beta-2 (LAMB2).